Ivy, D Dunbar <br/><br/>
Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan.  [electronic resource] 

 -  The American journal of cardiology  Apr 2004 
 - 943-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/j.amjcard.2003.12.031  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antihypertensive Agents--administration & dosage<br/>Blood Pressure--physiology<br/>Bosentan<br/>Child<br/>Child, Preschool<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Epoprostenol--administration & dosage<br/>Female<br/>Humans<br/>Hypertension, Pulmonary--drug therapy<br/>Male<br/>Sulfonamides--administration & dosage<br/>Vascular Resistance--physiology